Cover Image
市場調查報告書

Tobramycin的中國市場分析

Investigation Report on China Tobramycin Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 336269
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Tobramycin的中國市場分析 Investigation Report on China Tobramycin Market, 2010-2019
出版日期: 2015年07月24日 內容資訊: 英文 30 Pages
簡介

Tobramycin是以前就存在的抗生素,作為眼睛感染疾病和發炎的治療藥,以眼藥和軟膏的形廣泛用於處方。近幾年中國的Tobramycin市場表現沉著,在主要19醫院的2014年銷售額是2012萬人民幣 (與前一年同期比較增加3.93%),2010∼2014年的年複合成長率(CAGR) 為1.22%。

本報告提供中國的Tobramycin的市場相關分析,市場整體規模趨勢(過去5年份)和國內價格趨勢,各企業、各投藥形態的市場佔有率,主要製造商簡介,未來市場趨勢預測(今後5年份)等調查評估。

第1章 Tobramycin的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Tobramycin市場概況

  • 中國國內的Tobramycin的專利申請、認證情形
  • 主要製造商
  • 市場規模

第3章 Tobramycin銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Tobramycin市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (銷售額為基礎)
  • 市場佔有率 (銷售量為基礎)

第5章 中國的Tobramycin市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (銷售額為基礎)
  • 各劑型的市場佔有率 (銷售量為基礎)

第6章 Tobramycin的醫院用標準價格

  • S.A. Alcon-Couvreur N.V. (商標名:Tobrex)
  • Sine Pharma (商標名:Xintuoming)
  • Kangya of Ningxia Pharmaceuticals Co., Ltd
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd

第7章 中國國內的Tobramycin的主要製造商 (過去5年份)

  • S.A. Alcon-Couvreur N.V.
  • Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
  • Kangya of Ningxia Pharmaceuticals Co., Ltd
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
  • Humanwell Healthcare Group Co., Ltd

第8章 中國的Tobramycin市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1507278

With economic development and the prevalence of computer in work and life, the number of people suffering from eye problems increases by millions each year in China. Therefore, the demand for eye drops to treat infection, inflammation and asthenopia has increased sharply, which boosts the market expansion of relevant drugs. Driven by new drugs, added indications of old drugs and application of drug release technology, ophthalmic drugs have become a category which has attracted much attention.

Tobramycin is a traditional antibiotic whose eye drop and ointment are the most common prescription drugs for the treatment of potential infection or inflammation caused by eye infection. Currently, dozens of enterprises in China are able to produce tobramycin, among which the TOP5 are s.a. Alcon-Couvreur n.v., Sine Pharma, Kangya of Ningxia Pharmaceuticals Co., Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd and Shanghai Harvest Pharmaceutical Co., Ltd who together dominate the market by taking up a share of over 90%.

Tobramycin has begun to stabilize in recent years despite a rapid development ever since its entry into China. According to the statistics of 22 sample hospitals in key cities, the sales value of tobramycin was CNY 20.12 million in 2014 with a year-on-year growth of 3.93% and CAGR during the period of 2010-2014 reached 1.22%. As the incidence of eye disease keeps going up, tobramycin still enjoys a vast market in China. Although s.a. Alcon-Couvreur n.v. took up the largest market share of about 72% for sales value in 2014, local enterprises reported a fast growth in market share due to their increasing emphasis on ophthalmic drugs, which brought about a decline of 4.64% to s.a. Alcon-Couvreur n.v. in 2014. As local enterprises continue to progress, their market share is expected to keep growing in the next few years despite a dominance of imported drug in tobramycin market.

Readers can get at least the following information from this report:

  • market size of tobramycin in China
  • competitive landscape of tobramycin in Chinese market
  • price of tobramycin made by different enterprises in China
  • market outlook of tobramycin in China

The author suggests the following groups of people purchase this report:

  • manufacturers of ophthalmic drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Tobramycin

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Tobramycin in China

  • 2.1. Patent Status and Approval Information of Tobramycin in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Tobramycin in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Tobramycin in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Tobramycin in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Tobramycin in Chinese Hospitals in 2014

  • 6.1. S.A. Alcon-Couvreur N.V. (Trade Name: Tobrex)
  • 6.2. Sine Pharma (Trade Name: Xintuoming)
  • 6.3. Kangya of Ningxia Pharmaceuticals Co., Ltd
  • 6.4. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd

7. Major Manufacturers of Tobramycin in Chinese Market, 2010-2014

  • 7.1. S.A. Alcon-Couvreur N.V.
  • 7.2. Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
  • 7.3. Kangya of Ningxia Pharmaceuticals Co., Ltd
  • 7.4. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
  • 7.5. Humanwell Healthcare Group Co., Ltd

8. Market Outlook of Tobramycin in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Status of Tobramycin in China
  • Chart Approval Information of Tobramycin in China
  • Chart Sales Status of Tobramycin in China
  • Chart Sales Value of Tobramycin in China, 2010-2014
  • Chart Sales Value of Tobramycin in Some Regions in China, 2010-2014
  • Chart Sales Volume of Tobramycin in China, 2010-2014
  • Chart Sales Volume of Tobramycin in Some Regions in China, 2010-2014
  • Chart Sales Value and Market Share of Tobramycin Made by s.a. Alcon-Couvreur n.v. in China, 2010-2014
  • Chart Sales Value and Market Share of Tobramycin Made by Sine Pharma in China, 2010-2014
  • Chart Sales Value and Market Share of Tobramycin Made by Kangya of Ningxia Pharmaceuticals Co., Ltd in China, 2010-2014
  • Chart Sales Value and Market Share of Tobramycin Eye Drop in China, 2010-2014
  • Chart Sales Value and Market Share of Tobramycin Eye Ointment in China, 2010-2014
  • Chart Sales Value and Market Share of Tobramycin Injection in China, 2010-2014
  • Chart Price of Tobramycin Made by s.a. Alcon-Couvreur n.v. in Some Chinese Cities in 2014
  • Chart Price of Tobramycin Made by Sine Pharma in Some Chinese Cities in 2014
  • Chart Price of Tobramycin Made by Kangya of Ningxia Pharmaceuticals Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Tobramycin Made by Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top